Organizational Reviewer AACVPR Abbott Boehringer Ingelheim GlaxoSmithKline Pfizer Upsher Smith Amarin* AstraZeneca None None None None None Alice M. Mascette Organizational Reviewer NHLBI None None None None None None (Continued) Appendix B. Continued Peer Reviewer Representation Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Frederick A. Masoudi Content Reviewer ACC NCDR Science and Quality Oversight Committee Content Reviewer AHA None None None None None None Laura Mauri Official Reviewer AHA Abbott Cordis Johnson & Johnson Medtronic None None Abbott Abiomed Boston Scientific Bristol-Myers Squibb Cordis Daiichi Sankyo Eli Lilly Johnson & Johnson Medtronic Sanofi-Aventis Harvard Clinical Research Institute None None James K. Min Content Reviewer ACC Appropriate Use Criteria Task Force None GE Healthcare TC3* Phillips Healthcare* Arineta* None None Manesh R. Patel Content Reviewer ACC Appropriate Use Criteria Task Force None None None None None None Eric D. Peterson Official Reviewer ACC/AHA Task Force on Performance Measures Boehringer Ingelheim Genentech Janssen Pharmaceuticals Johnson & Johnson Merck None None Eli Lilly Johnson & Johnson Janssen Pharmaceuticals DCRI None Sunil V. Rao Official Reviewer SCAI AstraZeneca Bristol-Myers Squibb Cordis Daiichi Sankyo Terumo Medical The Medicines Company None None Sanofi-Aventis Abbott Vascular* None None Matthew T. Roe Content Reviewer ACC NCDR Science and Quality Oversight Committee KAI Pharmaceuticals Daiichi Sankyo GlaxoSmithKline Janssen Pharmaceuticals Eli Lilly Bristol-Myers Squibb Sanofi-Aventis None AstraZeneca Bristol-Myers Squibb Eli Lilly Merck Roche Pharmaceuticals Sanofi-Aventis AstraZeneca* AstraZeneca lectures performed within DCRI None Frank Rybicki Content Reviewer ACC/AHA/ACR/AMA- PCPI/NCQA Cardiac Imaging Writing Committee None None None Bracco Diagnostics Toshiba Medical Systems None None Leslee Shaw Content Reviewer ACC Appropriate Use Criteria Task Force None None None Bracco Diagnostics None None Marc Shelton Content Reviewer ACC Board of Governors None None None None None None John Spertus Content Reviewer ACC Appropriate Use Criteria Coronary Revascularization Genentech United Healthcare Scientific Advisory Board Amgen None None Eli Lilly CV Outcomes* None (Continued) Nallamothu et al ACC/AHA/SCAI/AMA-PCPI/NCQA 2013 PCI Performance Measure 947 Appendix B. 